Executive Vice President and President, Interventional Segment
Simon D. Campion serves as executive vice president and president of the Interventional segment of BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. In this role, he is responsible for driving the global operational, commercial and financial performance of the three business units that comprise the segment, including BD Peripheral Intervention, BD Surgery and BD Urology & Critical Care. Campion is also a member of the BD Executive Leadership Team.
In 2017, when BD completed its acquisition of C. R. Bard, Inc., a leading medical technology company in the fields of vascular, urology and surgical specialty products, Campion was named worldwide president of the company’s newly created BD Surgery business unit. He was responsible for the integration of BD and Bard’s surgery-related offerings.
Campion joined Bard in 2008, initially serving as global marketing director for stents and stent grafts, and then he was named to marketing and general management roles of increased scope and responsibility within multiple Bard businesses, including as president of the company’s surgery business, Davol, after serving as its vice president and general manager.
Campion earned a bachelor’s degree in engineering and a doctorate in mechanical engineering from the University of Limerick, Ireland. He also earned a master’s degree in business administration from Open University in the United Kingdom.